Because infusion of haploidentical male mouse splenocytes

was found previously to prevent diabetes in NOD mice we looked for, but found no evidence of, persistent chimeric lymphocytes from haploidentical paternal origin within the dams’ splenocytes. Gestation per se appears to have no aggravating or ameliorating effects on pre-existent autoimmune beta cell destruction, but pregnancy from MHC partially Dinaciclib chemical structure mismatched males delays diabetes onset in female NOD mice. In type 1 diabetes, autoimmune mechanisms are involved in the destruction of the insulin-producing beta cells in the pancreatic islets of Langerhans leading to the eventual need for insulin replacement therapy in patients [1,2]. Pregnancy has the capacity to alter both immune CB-839 mw response and beta cell function, but its effects on the development of autoimmune diabetes are largely unknown. Pregnancy is reported to ameliorate autoimmune diseases [3–5] through establishing a privileged state of tolerance potentially by shifting immune responses towards a less inflammatory state (reviewed in Piccinni [6]). However, this may not be the case for type 1 diabetes. Pregnancy also increases insulin demand with an expansion of beta cell mass [7–9], and a

number of islet autoantibody-positive women develop diabetes during gestation [10]. Evidence in humans indicates that increasing insulin demand aggravates autoimmune diabetes, and that increasing insulin demand Adenosine triphosphate at a late stage of preclinical disease will anticipate the onset of clinical diabetes [11–13]. We reasoned that examining the effect of gestation in the non-obese diabetic (NOD) mouse may be informative with respect to accelerating or delaying the onset of autoimmune diabetes. Because it is reported that the relative matching of the fetus may be important in the maternal tolerance state, we further reasoned that partially or

fully mismatched fetuses may provide advantage in controlling maternal autoimmunity. We therefore mated NOD female mice with male NOD mice, major histocompatibility complex (MHC) haploidentical mice and fully MHC mismatched mice and followed the female mice for diabetes development during and after pregnancy. The findings of our study are inconsistent with the notion that pregnancy accelerates the development of autoimmune diabetes, but support amelioration when mating is with haploidentical males. NOD mice were obtained originally from Taconics (Germantown, NY, USA) and C57BL/6J mice from The Jackson Laboratory (Bar Harbor, ME, USA), and the colonies established in the animal facilities at the Diabetes Research Institute Munich. The frequency of diabetes within untreated female NOD mice at the time of the study was 89% at age 36 weeks. Four male CByB6F1/J mice, F1 hybrids of female BALB/cByJ and male C57BL/6J mice were purchased at age 8 weeks from The Jackson Laboratory.